- Faculty
- BR1DGE
Alice Long
Benaroya Research Institute Washington, USA
Our ability to predict and monitor T1D is growing faster than ever before; education about these advances is essential so people can understand their disease and the choices they have now and in the future for treatment.
Dr. Alice Long is a translational immunologist who focuses on studying samples from clinical trial participants and individuals with T1D. Dr. Long earned her PhD in immunology at Emory University where she studied T cells in autoimmunity before expanding her knowledge of autoimmunity to autoantibody cross-reactivity during post-doctoral studies at UC Davis. Currently, she is an Associate Member at Benaroya Research Institute where she is seeking to understand how tolerance is lost in T1D and how it is restored with immune therapies. This includes in-depth analysis of the protective role of CD8 T cell exhaustion in T1D, the deleterious effects of defects in IL-2 signaling on T cell tolerance and characterizing early T cell phenotypes that initiate T1D autoimmunity. She hopes these studies will lead to biomarkers that predict disease progression and new therapeutic approaches to prevent T1D.
